• Advancing R&D for chronic diseases with AI: A conversation with Novo Nordisk’s CSO

  • Sep 18 2024
  • Duración: 26 m
  • Podcast

Advancing R&D for chronic diseases with AI: A conversation with Novo Nordisk’s CSO

  • Resumen

  • Marcus Schindler, chief scientific officer, and head of research and early development at Novo Nordisk, shares the ways in which he's leading the company’s efforts to embrace external innovation and expand into new therapeutic areas with AI as a powerful catalyst for progress with McKinsey colleagues Alex Devereson and Nav Nagra.

    Learn more about the McKinsey R&D practice here.

    See www.mckinsey.com/privacy-policy for privacy information

    Más Menos
activate_Holiday_promo_in_buybox_DT_T2

Lo que los oyentes dicen sobre Advancing R&D for chronic diseases with AI: A conversation with Novo Nordisk’s CSO

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.